Odds Ratio | p-value | [95% Conf. Interval] | |||
---|---|---|---|---|---|
uHIVinc (n = 1713) | |||||
Age group | 18–24 | ref. | |||
25–34 | 2.27 | 0.04 | 1.03 | 4.99 | |
35–44 | 1.62 | 0.29 | 0.67 | 3.90 | |
45–54 | 1.37 | 0.56 | 0.48 | 3.96 | |
55+ | 1.08 | 0.91 | 0.26 | 4.46 | |
Sexual role with last AI partner | top | ref. | |||
bottom | 1.12 | 0.73 | 0.60 | 2.07 | |
versatile | 2.05 | 0.01 | 1.18 | 3.55 | |
Type of drugs during last anal sex | no use of ecstasy, cocaine, amphetamine | ref. | |||
ecstasy, cocaine, amphetamine | 2.22 | 0.02 | 1.17 | 4.21 | |
no use of sexual performance substances (poppers, erectile dysfunction medication) | ref. | ||||
sexual performance substances (poppers, erectile dysfunction medication) | 1.96 | 0.01 | 1.17 | 3.28 | |
Serostatus disclosure to last AI partner | disclosure | ref. | |||
no disclosure | 3.94 | 0.00 | 2.14 | 7.27 | |
_cons | 0.01 | 0.00 | 0.00 | 0.01 | |
city | 0.40 | – | 0.11 | 1.45 | |
uHIVunk (n = 1639) | |||||
Age group | 18–24 | ref. | |||
25–34 | 2.00 | 0.16 | 0.76 | 5.27 | |
35–44 | 3.73 | 0.01 | 1.41 | 9.84 | |
45–54 | 3.31 | 0.04 | 1.08 | 10.12 | |
55+ | 0.90 | 0.93 | 0.10 | 7.84 | |
Number of partners with condomless anal intercourse | no partner | ref. | |||
1 partner | 1.46 | 0.38 | 0.63 | 3.36 | |
2–3 partners | 2.66 | 0.02 | 1.17 | 6.04 | |
4–5 partners | 6.08 | 0.00 | 2.26 | 16.40 | |
6–10 partners | 2.01 | 0.38 | 0.43 | 9.44 | |
> 10 partners | 12.83 | 0.00 | 3.60 | 45.65 | |
STI testing in last 12 months | no testing | ref. | |||
any STI testing | 3.61 | 0.00 | 1.74 | 7.50 | |
_cons | 0.02 | 0.00 | 0.01 | 0.07 | |
city | 0.00 | – | – | – | |
uHIV (n = 3745) | |||||
Age group | 18–24 | ref. | |||
25–34 | 2.36 | 0.00 | 1.33 | 4.19 | |
35–44 | 2.22 | 0.01 | 1.19 | 4.13 | |
45–54 | 1.90 | 0.09 | 0.91 | 3.94 | |
55+ | 0.85 | 0.78 | 0.27 | 2.66 | |
HIV test in last 12 months and knowing the result | not tested | ref. | |||
tested and knowing the result | 1.51 | 0.03 | 1.04 | 2.19 | |
Number of partners with condomless anal intercourse | no partner | ref. | |||
1 partner | 0.85 | 0.50 | 0.54 | 1.35 | |
2–3 partners | 1.28 | 0.30 | 0.81 | 2.03 | |
4–5 partners | 1.35 | 0.39 | 0.68 | 2.69 | |
6–10 partners | 1.56 | 0.25 | 0.74 | 3.29 | |
> 10 partners | 2.80 | 0.01 | 1.34 | 5.85 | |
Type of drugs during last anal sex | no use of sexual performance substances (poppers, erectile dysfunction medication) | ref. | |||
sexual performance substances (poppers, erectile dysfunction medication) | 1.91 | 0.00 | 1.32 | 2.76 | |
_cons | 0.01 | 0.00 | 0.01 | 0.02 | |
city | 0.32 | – | 0.10 | 1.01 |